GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Christopher & Banks Corp (OTCPK:CBKCQ) » Definitions » EBITDA

CBKCQ (Christopher & Banks) EBITDA : $-39.7 Mil (TTM As of Oct. 2020)


View and export this data going back to 1992. Start your Free Trial

What is Christopher & Banks EBITDA?

Christopher & Banks's EBITDA for the three months ended in Oct. 2020 was $-8.6 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Oct. 2020 was $-39.7 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

Christopher & Banks's EBITDA per Share for the three months ended in Oct. 2020 was $-0.23. Its EBITDA per share for the trailing twelve months (TTM) ended in Oct. 2020 was $-1.05.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.


Christopher & Banks EBITDA Historical Data

The historical data trend for Christopher & Banks's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Christopher & Banks EBITDA Chart

Christopher & Banks Annual Data
Trend Feb11 Jan12 Jan13 Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 -5.52 -10.21 -22.12 -7.63

Christopher & Banks Quarterly Data
Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.66 -3.12 -15.06 -12.98 -8.55

Competitive Comparison of Christopher & Banks's EBITDA

For the Apparel Retail subindustry, Christopher & Banks's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Christopher & Banks's EV-to-EBITDA Distribution in the Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Christopher & Banks's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Christopher & Banks's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Christopher & Banks's EBITDA for the fiscal year that ended in Jan. 2020 is calculated as

Christopher & Banks's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Jan. 2020, Christopher & Banks's EBITDA was $-7.6 Mil.

Christopher & Banks's EBITDA for the quarter that ended in Oct. 2020 is calculated as

Christopher & Banks's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Oct. 2020, Christopher & Banks's EBITDA was $-8.6 Mil.

EBITDA for the trailing twelve months (TTM) ended in Oct. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-39.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Christopher & Banks  (OTCPK:CBKCQ) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Christopher & Banks EBITDA Related Terms

Thank you for viewing the detailed overview of Christopher & Banks's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Christopher & Banks Business Description

Traded in Other Exchanges
N/A
Address
2400 Xenium Lane North, Plymouth, MN, USA, 55441
Christopher & Banks Corp is a national specialty retailer. The company through its wholly owned subsidiaries operates retail stores selling women's apparel and accessories in the United States. The company operates in Retail Operations which includes the operation of its retail stores, outlet stores, online and mobile. The company offers its customers an assortment of clothing for everyday needs. Its merchandise assortments include designs of women's apparel, generally consisting of casual clothing, everyday basics, wear-to-work, leisure/activewear, and sleepwear in missy, petite and women sizes. It also offers a selection of jewelry and accessories.
Executives
Keri L Jones director, officer: President & CEO 2400 XENIUM LANE NORTH, PLYMOUTH MN 55441
Andrea Kellick officer: SVP, CMO 2400 XENIUM LANE NORTH PLYMOUTH MN 55441
Rachel Endrizzi officer: Senior VP, Chief Mktg Officer 7201 METRO BLVD, MINNEAPOLIS MN 55439
Kent A Kleeberger director, other: Chair, Board of Directors
Mcm Managers, Llc 10 percent owner 99 HUDSON STREET 5TH FLOOR NEW YORK NY 10013
Mcm Management, Llc 10 percent owner 99 HUDSON STREET 5TH FLOOR NEW YORK NY 10013
Macellum Retail Opportunity Fund, Lp 10 percent owner 99 HUDSON ST. 5TH FLOOR NEW YORK NY 10013
Seth R Johnson director
Allison M. Wing director 1909 HUMBOLDT AVENUE, MINNEAPOLIS MN 55403
Sharpe William F. Iii director 18504 HEATHCOTE DRIVE DEEPHAVEN MN 55391
Jonathan Duskin director, 10 percent owner MACELLUM CAPITAL MANAGEMENT, LLC, 99 HUDSON STREET, 5TH FLOOR, NEW YORK NY 10013
Macellum Capital Management, Llc 10 percent owner 512 7TH AVENUE 40TH FLOOR NEW YORK NY 10018
Macellum Management, Lp 10 percent owner 99 HUDSON STREET, 5TH FLOOR, NEW YORK NY 10013
Macellum Advisors Gp, Llc 10 percent owner 99 HUDSON STREET, 5TH FLOOR, NEW YORK NY 10013
Luke Komarek officer: SVP, General Counsel 2400 XENIUM LANE N. PLYMOUTH MN 55441

Christopher & Banks Headlines

From GuruFocus

MaziValue March Performance

By MV Research mazivalue 04-06-2016

My Favorite Apparel Store Dividend Stocks

By Dividend Dividend 09-14-2011

Christopher & Banks Q1 Results - Signs of Hope

By Elie Rosenberg Elie Rosenberg 07-01-2011

Deep Value With Women's Apparel: Christopher & Banks Corp

By shadowstock shadowstock 12-14-2017

The Case for Christopher & Banks Corporation

By MV Research MaziValue 11-17-2015

Weekly CFO Buys Highlight: Christopher & Banks, Actuant, Catalyst Biosciences

By Myra Ramdenbourg Myra Ramdenbourg 12-28-2015